General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Eli-Lilly, Roche(MODEST), Toshiba(MODEST), Jansen(MODEST), Reckitt Benckiser Pharmaceuticals Inc.(MODEST), Pfizer(MODEST), AstraZeneca(SIGNIFICANT), Bristol-Myers Squibb Company (SIGNIFICANT), GlaxoSmithKline(SIGNIFICANT), CellProthera(MODEST), Oncoarendi(MODEST) RESEARCH/RESEARCH GRANTS: Pfizer(SIGNIFICANT), AstraZeneca(SIGNIFICANT), Bristol-Myers Squibb Company (SIGNIFICANT), GlaxoSmithKline(SIGNIFICANT), Merck & Co., Inc.(SIGNIFICANT), Boeringer Ingelheim(SIGNIFICANT), Life Molecular Imaging(NONE), ICTargets(NONE), Inositec(MODEST)

View Full Disclosure